Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics (PREDAFLU)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified August 2016 by Centre Hospitalier Universitaire de Saint Etienne
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier:
NCT02858531
First received: August 1, 2016
Last updated: August 3, 2016
Last verified: August 2016
  Purpose

Epidemics and infectious diseases in general, punctuate much of the activity of an emergency service. The impact of winter infections is particularly important to vulnerable populations such as infant during bronchiolitis epidemics and the elderly during seasonal influenza. Each year, these epidemic phenomena lead to disorganization of emergency services and healthcare teams by lack of anticipation and organizational measures in particular to manage the approval of emergency services for the most vulnerable populations requiring hospitalization.

For 2 years, the pediatric emergency department of St Etienne University Hospital has a decision support tool for the periods of winter epidemics. Through a retrospective analysis of Passages of Emergency summary, this tool provides an estimate of infants with bronchiolitis flow day to day, and the availability in real time of an abnormally high flow of patients to pediatric emergencies. These data can help to affirm that the epidemic begins in this hospital.


Condition Intervention
Disease Outbreaks
Child
Elderly
Bronchiolitis
Acute Renal Failure
Other: data retrieval

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics

Resource links provided by NLM:


Further study details as provided by Centre Hospitalier Universitaire de Saint Etienne:

Primary Outcome Measures:
  • build a predictive tool [ Time Frame: at inclusion ]

    a tool with different levels of alerts of the influx of people aged to emergencies during winter epidemics.

    Variables in the model : activity database in emergency services, computer data, virology database and average length of stay.



Secondary Outcome Measures:
  • Difference between the estimated date and the effective date of the activity peak on the average length of stay of patients in the hospital of Saint Etienne [ Time Frame: at inclusion ]
  • Difference between the estimated date and the effective date of the activity peak on the average length of stay of patients in the other hospitals [ Time Frame: at inclusion ]
  • Comparison virological databases with clinical diagnosis of patients [ Time Frame: at inclusion ]
  • Percentage of elderly staying more than 10 hours in the emergency services. [ Time Frame: at inclusion ]

Estimated Enrollment: 760000
Study Start Date: September 2016
Estimated Study Completion Date: October 2019
Estimated Primary Completion Date: October 2019 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
patients < 24 months or 60 years with bronchiolitis or ARF
ARF = Acute Renal Failure
Other: data retrieval
data retrieval with the Hospital Information System

  Eligibility

Ages Eligible for Study:   1 Month and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
child < 24 months with bronchiolitis or elderly < 60 years with acute renal failure
Criteria

Inclusion Criteria:

  • child < 24 months with bronchiolitis
  • elderly < 60 years with acute renal failure or breathing problem

Exclusion Criteria:

  • refuse of transmission of their data
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02858531

Contacts
Contact: Olivier MORY, MD (0)4 77 82 81 34 olivier.mory@chu-st-etienne.fr
Contact: Béatrice DEYGAS (0)4 77 12 76 55 beatrice.deygas@chu-st-etienne.fr

Locations
France
CHU de Grenoble (adult emergency service) Not yet recruiting
Grenoble, France, 38000
Contact: Françoise CARPENTIER, MD PhD         
Principal Investigator: Françoise CARPENTIER, MD PhD         
CHU de Grenoble (laboratory of virology) Not yet recruiting
Grenoble, France, 38000
Contact: Patrice MORAND, MD PhD         
Principal Investigator: Patrice MORAND, MD PhD         
CHU de Grenoble (pediatric service) Not yet recruiting
Grenoble, France, 38000
Contact: Anne Pascale MICHARD LENOIR, MD         
Principal Investigator: Anne Pascale MICHARD LENOIR, MD         
Sub-Investigator: Catherine BARBIER, MD         
CHU de Lyon (adult emergency service) Not yet recruiting
Lyon, France, 69000
Contact: Pierre-Yves GUEUGNIAUD, MD PhD         
Principal Investigator: Pierre-Yves GUEUGNIAUD, MD PhD         
CHU de Lyon (laboratory of virology) Not yet recruiting
Lyon, France, 69000
Contact: Bruno LINA, MD PhD         
Principal Investigator: Bruno LINA, MD PhD         
Sub-Investigator: Jean Sébastien CASALEGNO, MD         
CHU de Lyon HFME (pediatric service) Not yet recruiting
Lyon, France, 69000
Contact: Etienne JAVOUHEY, MD PhD         
Principal Investigator: Etienne JAVOUHEY, MD PhD         
Sub-Investigator: Yves GILLET, MD PhD         
CHU de Saint Etienne (adult emergency service) Not yet recruiting
Saint Etienne, France, 42055
Contact: Alain VIALLON, MD         
Principal Investigator: Alain VIALLON, MD         
CHU de Saint Etienne (laboratory of virology) Not yet recruiting
Saint Etienne, France, 42055
Contact: Bruno POZZETTO, MD PhD         
Principal Investigator: Bruno POZZETTO, MD PhD         
Sub-Investigator: Sylvie PILLET, MD         
CHU de Saint Etienne (Pediatric service) Not yet recruiting
Saint Etienne, France, 42055
Contact: Olivier MORY, MD    (0)4 77 82 81 34 ext +33    olivier.mory@chu-st-etienne.fr   
Principal Investigator: Olivier MORY, MD         
Sub-Investigator: Aymeric CANTAIS, MD         
CH de Valence (adult emergency service) Not yet recruiting
Valence, France, 26000
Contact: Claude ZAMOUR, MD         
Principal Investigator: Claude ZAMOUR, MD         
CH de Valence (pediatric service) Not yet recruiting
Valence, France, 26000
Contact: Agnès VEAUVY-JUVEN, MD         
Principal Investigator: Agnès VEAUVY-JUVEN, MD         
Sub-Investigator: Julien CRON, MD         
CH de Villefranche (adult emergency service) Not yet recruiting
Villefranche Sur Saone, France, 69655
Contact: Bruno DUCREUX, MD         
Principal Investigator: Bruno DUCREUX, MD         
Sub-Investigator: Sandra DENISOFF, MD         
CH de Villefranche (pediatric service) Not yet recruiting
Villefranche Sur Saone, France, 69655
Contact: Philippe REBAUD, MD PhD         
Principal Investigator: Philippe REBAUD, MD PhD         
Sponsors and Collaborators
Centre Hospitalier Universitaire de Saint Etienne
Investigators
Principal Investigator: Olivier MORY, MD Centre Hospitalier Universitaire de Saint Etienne
  More Information

Responsible Party: Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier: NCT02858531     History of Changes
Other Study ID Numbers: 1508191
1969303 v 0 ( Other Identifier: CNIL )
Study First Received: August 1, 2016
Last Updated: August 3, 2016
Individual Participant Data  
Plan to Share IPD: No

Additional relevant MeSH terms:
Emergencies
Renal Insufficiency
Bronchiolitis
Acute Kidney Injury
Disease Attributes
Pathologic Processes
Kidney Diseases
Urologic Diseases
Bronchitis
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Infections

ClinicalTrials.gov processed this record on April 27, 2017